FDA approves 1st at-home nasal spray flu vaccine
The Washington Post · 2d
FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before expanding eligibility in 2007 to children as young as 2 years old — requiring in both instances that it be administered by a vaccine provider.
healthcarepackaging · 3h
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist contains a weakened form of live influenza virus strains and is sprayed in the nose. A prescription is still required.
CBS News · 2d
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
ScienceAlert · 12h
FDA Approves First Nasal Spray Flu Vaccine You Can Do at Home
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca's FluMist, which was authorized in 2003 to be administered by a health care provider, will be available to ordinary Americans through an online pharmacy.
STAT · 2d
FDA approves first at-home flu vaccine in U.S., a nasal spray
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages of 2 and 49. This FDA approval makes it the only flu vaccine in the United States that can be administered at home and that does not need to be administered by a health care professional.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results